Vimarsana.com

Latest Breaking News On - Pharma stock down - Page 6 : vimarsana.com

Silo Pharma (NASDAQ:SILO) Receives New Coverage from Analysts at Laidlaw

Laidlaw assumed coverage on shares of Silo Pharma (NASDAQ:SILO – Free Report) in a research report sent to investors on Monday, Marketbeat Ratings reports. The firm issued a buy rating and a $10.00 price objective on the stock. Silo Pharma Stock Down 0.4 % Shares of NASDAQ:SILO opened at $1.89 on Monday. Silo Pharma has […]

Geode-capital-management
Laidlaw
Nasdaq
Silo-pharma
Free-report
Marketbeat-ratings
Pharma-stock-down
Street-corp
Advocates-investment-management
Get-free-report
Silo-pharma-daily

StockNews.com Begins Coverage on China Pharma (NYSE:CPHI)

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research note published on Thursday. The brokerage issued a hold rating on the stock. China Pharma Stock Down 2.4 % China Pharma stock opened at $0.22 on Thursday. The company’s 50 day moving average is $0.31. China Pharma has a fifty-two […]

China-pharma-holdings-inc
China-pharma
Free-report
Pharma-stock-down
Get-free-report
Pharma-holdings
China-pharma-daily
Nyse-cphi
Cphi
Medical
Initiated-coverage

Evoke Pharma (NASDAQ:EVOK) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a report released on Tuesday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Stock Down 1.8 % Shares of EVOK stock opened at $1.08 on Tuesday. The stock’s 50 day simple moving average is $1.53 and […]

Pharma-company-profile
Pharma-inc
Evoke-pharma
Free-report
Pharma-stock-down
Get-free-report
Evoke-pharma-daily
Nasdaq-evok
Revok
Medical
Initiated-coverage

Evoke Pharma (NASDAQ:EVOK) Stock Passes Below 200 Day Moving Average of $2.10

Shares of Evoke Pharma, Inc. (NASDAQ:EVOK – Get Free Report) passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $2.10 and traded as low as $1.12. Evoke Pharma shares last traded at $1.15, with a volume of 26,968 shares traded. Wall […]

Pharma-inc
Nasdaq
Evoke-pharma
Get-free-report
Pharma-stock-down
Evoke-pharma-daily
Nasdaq-evok
Revok
Medical
Stocks
Technicals

Ocuphire Pharma, Inc. (NASDAQ:OCUP) to Post FY2027 Earnings of $1.06 Per Share, HC Wainwright Forecasts

Ocuphire Pharma, Inc. (NASDAQ:OCUP) to Post FY2027 Earnings of $1.06 Per Share, HC Wainwright Forecasts
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Ocuphire-pharma
Ocuphire-pharma-inc
Stratos-wealth-partners
Legato-capital-management
Rice-hall-james-associates
Acadian-asset-management
Cantor-fitzgerald
Nasdaq
Richmond-brothers-inc
Free-report
Pharma-stock-down
Get-free-report

Insider Buying: Vincerx Pharma, Inc. (NASDAQ:VINC) Insider Acquires $16,055.00 in Stock

Insider Buying: Vincerx Pharma, Inc. (NASDAQ:VINC) Insider Acquires $16,055.00 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Vincerx-pharma
Vincerx-pharma-inc
Securities-exchange-commission
Sage-rhino-capital
Schonfeld-strategic-advisors
Vanguard-group-inc
Nasdaq
Affinity-asset-advisors
Get-free-report
Ahmed-md-hamdy
Exchange-commission

Terrance P. Coyne Sells 37,500 Shares of Royalty Pharma plc (NASDAQ:RPRX) Stock

Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) CFO Terrance P. Coyne sold 37,500 shares of the firm’s stock in a transaction on Wednesday, August 9th. The stock was sold at an average price of $30.72, for a total transaction of $1,152,000.00. Following the completion of the sale, the chief financial officer now owns 827,500 […]

United-states
Terrancep-coyne
Nasdaq
Sageworth-trust-co
Morgan-stanley
International-assets-investment-management
Royalty-pharma
Get-free-report
Pharma-stock-down
Forest-capital-management
Financial-advisors

Q3 2023 EPS Estimates for Inozyme Pharma, Inc. Lifted by Analyst (NASDAQ:INZY)

Q3 2023 EPS Estimates for Inozyme Pharma, Inc. Lifted by Analyst (NASDAQ:INZY)
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

United-states
Inozyme-pharma
Needham-company
Inozyme-pharma-inc
Affinity-asset-advisors
Nasdaq
Blackrock-inc
Sphera-funds-management
Free-report
Get-free-report
Pharma-stock-down
Funds-management

Athira Pharma (NASDAQ:ATHA) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS

Athira Pharma (NASDAQ:ATHA) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Wisconsin
United-states
Athira-pharma
Andrew-gengos
Squarepoint-ops
Tower-research-capital
Athira-pharma-inc
First-republic-investment-management-inc
Balyasny-asset-management
Yahoo
Get-free-report
Yahoo-finance

Lumos Pharma (NASDAQ:LUMO) Rating Reiterated by HC Wainwright

Lumos Pharma (NASDAQ:LUMO) Rating Reiterated by HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Lumos-pharma
Millennium-management
Advisor-group
Jefferies-financial-group-inc
Shay-capital
Lumos-pharma-inc
Cantor-fitzgerald
Virtu-financial
Get-free-report
Pharma-stock-down
Financial-group
Lumos-pharma-daily

vimarsana © 2020. All Rights Reserved.